ClearSky heads to Parkinson’s Congress in Nice

ClearSky heads to Parkinson’s Congress in Nice

The ClearSky Medical Diagnostics team will be attending the 23rd International Congress of Parkinson’s Disease and Movement Disorders (MDS) in September. The Congress brings together global experts on neurodegenerative and neurodevelopmental disorders, including...
ClearSky receives CE Mark for PD-Monitor

ClearSky receives CE Mark for PD-Monitor

ClearSky’s PD-Monitor, a device designed to assist with the diagnosis of Parkinson’s, has achieved CE Mark approval. A CE mark indicates that the medical device has met all applicable directives of the European Commission and, subsequently, the laws and...
ClearSky targets Royal approval at Pitch@Palace

ClearSky targets Royal approval at Pitch@Palace

ClearSky Medical Diagnostics is thrilled to announce its selection to take part in a Duke of York initiative that supports innovative businesses and accelerates their business ideas. The Pitch@Palace competition, launched by Prince Andrew the Duke of York in 2014, is...
ClearSky update: a look back

ClearSky update: a look back

Looking back at some of ClearSky Medical Diagnostics’ achievements over the past 12 months. 2019 is underway with exciting plans to launch new products and clinical trials, let’s take a look back at some of the recent highlights for ClearSky MD. China paper:...